“ab fubinaca”的搜索结果

7 个项目

每页

设置升序顺序
  1. Kynurenic acid

    Catalog No. A16581
    Quick View
    GPR35/CXCR8 拮抗剂
    Kynurenic acid, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid is also an agonist of GPR35/CXCR8. 了解更多
  2. LY2922470

    Catalog No. A12181
    Quick View
    GPR40 agonist
    LY2922470 is a potent, selective and orally available agonist of the G protein-coupled receptor 40 (GPR40), with EC50s of 7 nM, 1 nM and 3 nM for human GPR40, mouse GPR40 and rat GPR40, respectively. 了解更多
  3. GPR35 agonist 1

    Catalog No. A12462
    Quick View
    GPR35/CXCR8 agonist
    GPR35 agonist 1 (compound 50) is a potent and specific G protein-coupled receptor-35 (GPR35)/CXCR8 agonist with an EC50 of 5.8 nM, displays good druggability. 了解更多
  4. Kynurenic acid sodium

    Catalog No. A20000
    Quick View
    GPR35/CXCR8 agonist
    Kynurenic acid sodium, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid sodium is also an agonist of GPR35/CXCR8. 了解更多
  5. GPR40 Activator 1

    Catalog No. A21154
    Quick View
    GPR40 activator
    GPR40 Activator 1 is a potent GPR40 activator for treatment of type 2 diabetes. 了解更多
  6. AM-1638

    Catalog No. A21505
    Quick View
    GPR40/FFA1 full agonist
    AM-1638 is a potent and orally bioavailable GPR40/FFA1 full agonist with an EC50 of 0.16 μM. 了解更多
  7. AM-4668

    Catalog No. A21778
    Quick View
    GPR40 agonist
    AM-4668 is a GPR40 agonist for type 2 diabetes. EC50s of 3.6 nM and 36 nM for GPR40 in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), respectively. 了解更多

7 个项目

每页

设置升序顺序
Rewards